P. Fábregas

发表

Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer

O. Díez, V. Volpini, J. Balmaña, 2013, Breast Cancer Research and Treatment.

Competition between plasminogen and tissue plasminogen activator for cellular binding sites.

Jordi Félez, E. Plow, L. Miles, 1993, Blood.

Monoclonal antibodies against receptor-induced binding sites detect cell-bound plasminogen in blood.

M. Jardí, L. Miles, P. Fábregas, 2012, Blood.

Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87).

Jordi Félez, P. Fábregas, R. Merton, 1999, Blood.

Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase

Jordi Félez, R. López-Alemany, M. Jardí, 2003, American journal of hematology.

Regulation of Tissue Plasminogen Activator Activity by Cells

V. Sinniger, Jordi Félez, P. Fábregas, 1999, The Journal of Biological Chemistry.

Characterization of Cellular Binding Sites and Interactive Regions within Reactants Required for Enhancement of Plasminogen Activation by tPA on the Surface of Leukocytic Cells

Jordi Félez, M. Jardí, R. Lijnen, 1996, Thrombosis and Haemostasis.

Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations

C. Lázaro, E. Serra, E. Pros, 2008, Human mutation.

Procoagulant Activity of T Lymphoblastoid Cells due to Exposure of Negatively Charged Phospholipid

J. Cancelas, Jordi Félez, M. Jardí, 2002, Thrombosis and Haemostasis.

Characterization of Plasminogen Binding to NB4 Promyelocytic Cells Using Monoclonal Antibodies against Receptor-Induced Binding Sites in Cell-Bound Plasminogen

M. Jardí, P. Fábregas, María Sagarra-Tió, 2012, Journal of biomedicine & biotechnology.

Plasminogen Binding Properties of Macrophage Inflammatory Protein (MIP)-2α

Jordi Félez, D. Collen, H. Lijnen, 2000, Thrombosis and Haemostasis.